Skip to content
Home/Companies/Biotech/Iktos
Iktos

Iktos

Biotech·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Iktos?

Iktos is a French Biotech company, currently owned by Omnes Capital since 2022.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Omnes Capital
Investor
Omnes Capital
Omnes Real Tech 1 · 2018 · VC

Key facts

HQFrance
SectorBiotech
Websiteiktos.ai

More from Omnes Real Tech 1

Other portfolio companies in the same fund.

DiogenX
Active
BiotechFrance· 2023
Jimmy Energy
Active
ClimateTechFrance· 2023
Planet A Foods
Planet A Foods
Active
FoodTechGermany· 2023
Quantum Systems
Quantum Systems
Active
Aerospace & DefenceGermany· 2023
Lithosquare
Lithosquare
Active
IndustrialsFrance· 2022
OpenSee
OpenSee
Active
AI/MLFrance· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Iktos?

Iktos is currently owned by Omnes Capital, through Omnes Real Tech 1, since 2022.

When did Omnes Capital acquire Iktos?

Omnes Capital acquired Iktos in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue